We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
Sanofi Pasteur, the manufacturer of Stamaril yellow fever vaccine have updated the Summary of Product Characteristics (SmPC).
The SmPC for Stamaril yellow fever vaccine now states:
“The tip caps of prefilled syringes contain a natural rubber latex derivative, which may cause allergic reactions in latex sensitive individuals.”
Health care professionals are reminded that they must take an accurate medical history and complete a risk assessment before administering any vaccine.
Please note:
Travellers considering yellow fever vaccination should read the following fitfortravel pages prior to vaccination: